Panolos Bioscience specializes in protein structure and develops anticancer drugs using αART, an independent drug development platform
Investors 1
| Date | Name | Website |
| - | UTC Invest... | utc.co.kr |
Mentions in press and media 1
| Date | Title | Description |
| 22.09.2023 | Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development | Chime Biologics and Panolos Bioscience have entered into a global strategic collaboration agreement on a novel multi-specific protein drug. Chime Biologics will provide development and manufacturing services to Panolos Bioscience for PB203,... |